Fidelity Select Portfolios - Pharmaceuticals Portfolio(NASDAQMUTFUND) FPHAX
| Metric | Price | Date |
|---|---|---|
| Last close | USD 35.14 | 2026-10-16 |
| Period | Price return | Price at period start | Period start date |
|---|---|---|---|
| 1 week | +2% | USD 34.45 | 2026-10-09 |
| 1 month | +2.81% | USD 34.18 | 2026-09-16 |
| 3 month | +2.69% | USD 34.22 | 2026-07-17 |
| Year to date | +16.53% | USD 30.15 | 2025-12-31 |
| 1 year | +29.5% | USD 27.14 | 2025-10-16 |
| 3 year | +70.65% | USD 20.59 | 2023-10-17 |
| 5 year | +94.07% | USD 18.11 | 2021-10-15 |
| Since inception | +1,035.69% | USD 3.09 | 2001-07-11 |
Fidelity Select Portfolios - Pharmaceuticals Portfolio Financials at a Glance
Market Cap
Revenue (TTM)
Net Income (TTM)
EPS (TTM)
P/E Ratio
Dividend
Beta (Volatility)
Dividend
Beta (Volatility)
Price
Volume
Open
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
Dividend
Beta (Volatility)
Price
Volume
Open
Previous Close
Daily Range
52-Week Range
Estimated Earnings Date
FPHAX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowFPHAX Financials
Key Financial Metrics (TTM)
Gross Margin
Operating Margin
Net Income Margin
Return on Equity
Return on Capital
Return on Assets
Earnings Yield
Dividend Yield
Payout Ratio
Stock Overview
Market Cap
Shares Outstanding
Volume
Avg. Volume
Financials (TTM)
Gross Profit
Operating Income
EBITDA
Operating Cash Flow
Capital Expenditure
Free Cash Flow
Cash & ST Invst.
Total Debt